Join ASGCT
|
Contact Us
|
Site Map
|
Home
Membership
Benefits of Membership
Types of Membership
Applying for Membership
Members Only
• My Profile
• My History
• Member Directory
• Renew My Dues
• Change Username and Password
• Logout
About the Society
Our Mission
History and Overview
Position Statements
Bylaws
Code of Ethics
Board, Officers and Advisory Council
Committee Members
ASGCT Official Journal -
Molecular Therapy
Annual Meeting/Workshops
Future Annual Meetings
& Courses
Archived Meetings Information
Archived Course Materials
Resources for Members
Member Directory
Job Bank
ASGCT Grants/Awards
General Grant Information
New Investigator Center of Educational Resources (NICER)
Regulatory Affairs Information
• Federal Agencies that
Regulate Gene Therapy
• FDA References for the
Regulatory Process
• Clinical Trials and Regulatory
Affairs Information
• Regulatory Issues Archive
Related Sites of Interest
Welcome New Society Members!
Educational Resources
Information about Gene and Cell Therapy
• Gene and Cell Therapy Defined
• Common Gene and Cell
Therapy Terms
• Gene and Cell Therapy
for Diseases
• Gene Therapy in Germany
Resources for Patients
• About Clinical Trials
• Finding a Clinical Trial
Media Resources
• Gene and Cell Therapy
in the News
• ASGCT News Releases
• Guide to ASGCT Gene
and Cell Therapy Experts
• ASGCT Position Statements
2008 Annual Meeting
ASGT Special Plenary Session Evaluation
May 30, 2008
Special Plenary Session 320
1:30 pm – 3:30 pm
PRESENTATION RATINGS
Presenter/Topic
Overall Rating
Excellent
Good
Average
Poor
Very Poor
376. Ta-Chiang Liu, MD, PhD
- Clinical Proof-of-Concept with JX-594, a Novel Targeted Multi-Mechanistic Oncolytic Poxvirus, in Patients with Refractory Liver Tumors
377. Chiara Bonini, MD
- Transfer of a Suicide Gene into Donor Lymphocytes Allows Early and Effective Immune-Reconstitution after Family Haploidentical Hematopoietic Stem Cell Transplantation for Leukemias: Results of the TK007 Study
378. Toshifumi Yokota, PhD
- Body-Wide Restoration of Dystrophin Expression and Amelioration of Pathology in Dystrophic Dogs Using a Morpholino Cocktail
379. Defne Amado
- AAV-Mediated Delivery of Rod-Derived Cone Viability Factor: Towards a Mutation-Independent Prevention of Retinal Blindness
380. Yashuhiro Kazuki, PhD
- A Novel Human Artificial Chromosome (HAC) for Gene Therapy and Animal Transgenesis
381. Li Zhong, MD
- Next Generation of Recombinant Adeno-Associated Virus 2 Vectors: Point Mutations in Tyrosine Residues Lead to High-Efficiency Transduction at Lower Vector Doses
Comments
© 2000-2010 All rights reserved.
American Society of Gene & Cell Therapy
Disclaimer